These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 37540080

  • 1. RNA-Sequencing Analysis Indicates That N-Cadherin Promotes Prostate Cancer Progression by the Epigenetic Modification of Key Genes.
    Quan Y, Ping H, Wang M, Zhang X.
    DNA Cell Biol; 2023 Sep; 42(9):563-577. PubMed ID: 37540080
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W, Wang L, Mizokami A, Shi J, Zou C, Dai J, Keller ET, Lu Y, Zhang J.
    Chin J Cancer; 2017 Mar 29; 36(1):35. PubMed ID: 28356132
    [Abstract] [Full Text] [Related]

  • 3. The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells.
    Brett A, Pandey S, Fraizer G.
    Mol Cancer; 2013 Jan 08; 12():3. PubMed ID: 23298185
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Exosome carrying PSGR promotes stemness and epithelial-mesenchymal transition of low aggressive prostate cancer cells.
    Li Y, Li Q, Li D, Gu J, Qian D, Qin X, Chen Y.
    Life Sci; 2021 Jan 01; 264():118638. PubMed ID: 33164833
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model.
    Thomas-Jardin SE, Dahl H, Kanchwala MS, Ha F, Jacob J, Soundharrajan R, Bautista M, Nawas AF, Robichaux D, Mistry R, Anunobi V, Xing C, Delk NA.
    Prostate; 2020 Feb 01; 80(2):133-145. PubMed ID: 31730277
    [Abstract] [Full Text] [Related]

  • 8. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
    Shi X, Zhang W, Nian X, Lu X, Li Y, Liu F, Wang F, He B, Zhao L, Zhu Y, Ren S, Sun Y.
    Int J Cancer; 2020 Jan 15; 146(2):475-486. PubMed ID: 31107971
    [Abstract] [Full Text] [Related]

  • 9. Identification of the role of mono-ADP-ribosylation in colorectal cancer by integrated transcriptome analysis.
    Zhang S, Duan J, Yang Y, Gong H, Tang Y, Xiao M, Li M, Li Q, Wang Y.
    Med Oncol; 2021 Aug 06; 38(9):111. PubMed ID: 34357465
    [Abstract] [Full Text] [Related]

  • 10. Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells.
    Jo YK, Roh SA, Lee H, Park NY, Choi ES, Oh JH, Park SJ, Shin JH, Suh YA, Lee EK, Cho DH, Kim JC.
    Cancer Lett; 2017 Jan 28; 385():21-27. PubMed ID: 27836735
    [Abstract] [Full Text] [Related]

  • 11. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.
    Deep G, Jain AK, Ramteke A, Ting H, Vijendra KC, Gangar SC, Agarwal C, Agarwal R.
    Mol Cancer; 2014 Feb 24; 13():37. PubMed ID: 24565133
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. LncRNA SFTA1P promotes cervical cancer progression by interaction with PTBP1 to facilitate TPM4 mRNA degradation.
    Luo A, Lan X, Qiu Q, Zhou Q, Li J, Wu M, Liu P, Zhang H, Lu B, Lu Y, Lu W.
    Cell Death Dis; 2022 Nov 07; 13(11):936. PubMed ID: 36344495
    [Abstract] [Full Text] [Related]

  • 14. Androgen depletion up-regulates cadherin-11 expression in prostate cancer.
    Lee YC, Cheng CJ, Huang M, Bilen MA, Ye X, Navone NM, Chu K, Kao HH, Yu-Lee LY, Wang Z, Lin SH.
    J Pathol; 2010 May 07; 221(1):68-76. PubMed ID: 20191612
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long Noncoding RNA Small Nucleolar RNA Host Gene 3 Mediates Prostate Cancer Migration, Invasion, and Epithelial-Mesenchymal Transition by Sponging miR-487a-3p to Regulate TRIM25.
    Yu L, Ren Y.
    Cancer Biother Radiopharm; 2022 Aug 07; 37(6):451-465. PubMed ID: 33416420
    [Abstract] [Full Text] [Related]

  • 17. Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer.
    Chin SP, Marthick JR, West AC, Short AK, Chuckowree J, Polanowski AM, Thomson RJ, Holloway AF, Dickinson JL.
    Prostate; 2015 May 07; 75(7):723-34. PubMed ID: 25662931
    [Abstract] [Full Text] [Related]

  • 18. Correlation between methylation of the E-Cadherin gene and malignancy of prostate cancer.
    Zhang SQ, Zhang GQ, Zhang L.
    Genet Mol Res; 2016 Jul 14; 15(2):. PubMed ID: 27420993
    [Abstract] [Full Text] [Related]

  • 19. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
    Chen W, He LN, Liang Y, Zeng X, Wu CP, Su MQ, Cheng Y, Liu JH.
    Mol Med Rep; 2020 Dec 14; 22(6):5209-5218. PubMed ID: 33174061
    [Abstract] [Full Text] [Related]

  • 20. LncRNA FIRRE functions as a tumor promoter by interaction with PTBP1 to stabilize BECN1 mRNA and facilitate autophagy.
    Wang Y, Li Z, Xu S, Li W, Chen M, Jiang M, Fan X.
    Cell Death Dis; 2022 Feb 02; 13(2):98. PubMed ID: 35110535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.